propafenone has been researched along with Myoclonic Jerk in 3 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chua, TP | 1 |
Farrell, T | 1 |
Lipkin, DP | 1 |
Devoize, JL | 1 |
Flammang, D | 1 |
Marcombes, JL | 1 |
Madigand, M | 1 |
Dien, J | 1 |
Pavin, G | 1 |
Allain, H | 1 |
3 other studies available for propafenone and Myoclonic Jerk
Article | Year |
---|---|
Myoclonus associated with propafenone.
Topics: Aged; Aged, 80 and over; Female; Humans; Myoclonus; Propafenone | 1994 |
[Myoclonic encephalopathy probably due to propafenone].
Topics: Aged; Anti-Arrhythmia Agents; Female; Humans; Myoclonus; Propafenone; Propiophenones | 1986 |
[Myoclonic encephalopathy probably attributable to propafenone].
Topics: Aged; Humans; Male; Myoclonus; Propafenone | 1988 |